SOURCE: Spotlight Innovation Inc.

Spotlight Innovation Inc.

June 18, 2015 11:50 ET

Spotlight Innovation Retains DresnerAllenCaron as Its Investor Relations Firm

DresnerAllenCaron to Design and Execute Investor Relations Programs That Broaden Awareness and Visibility of Spotlight Innovation

WEST DES MOINES, IA--(Marketwired - Jun 18, 2015) - Spotlight Innovation Inc. (OTCQB: STLT) announces today that it has retained DresnerAllenCaron as its investor relations firm. DresnerAllenCaron will design and execute investor relations programs to broaden awareness and visibility of Spotlight Innovation within the investment community, and the business and financial media.

DresnerAllenCaron specializes in providing targeted investor relations and corporate communications financial market awareness services to micro-, small- and mid-cap companies. DresnerAllenCaron has three offices in the United States (New York City, Chicago and Irvine, CA) and international access through its affiliates in London and Milan.

Cris Grunewald, President and CEO of Spotlight Innovation, said, "We selected DresnerAllenCaron for the depth of their experience over the last 35 years with the investment community, and for their distinctive process-driven approach to assisting companies at our stage of growth. They understand our compelling story and will be able to articulate our vision to the investment community. We look forward to a strong relationship that positively impacts shareholder value and will assist us in achieving our goal of improving the health and well-being of as many people as possible."

Joe Allen, head of DresnerAllenCaron in New York City, commented, "We have always had a strong interest in healthcare and life sciences companies. We have a reputation on the Street for introducing growth and deep value investment opportunities to institutional investors. We believe we can significantly augment the audience following Spotlight Innovation. We also believe that Cris Grunewald's vision of a collegial biotech family based on university-developed drug innovations and nurtured by Spotlight Innovation is sound and viable." 

About Spotlight Innovation Inc.

Spotlight Innovation Inc. (OTCQB: STLT) specializes in identifying, acquiring and incubating companies that have unique intellectual property (IP) in the medical sector. The Company utilizes relationships with the nation's leading academic and institutional IP developers to locate promising IP technologies with potential for market share capture. With our support, development, resources and strategic planning expertise, we believe we can develop IP that will have a positive effect on healthcare. We intend to partner with proven sector leaders on commercialization once technologies are fully developed. Additional information available at www.spotlightinnovation.com.

About DresnerAllenCaron

DresnerAllenCaron was created by the merger of Dresner Corporate Services and Allen & Caron Inc in March, 2015. It has, for nearly 35 years, provided investor relations, media relations and corporate communications services to micro-, small- and mid-cap companies. With offices in New York City, Chicago and Irvine CA, and affiliations in London and Milan, it is one of very few independently owned investor relations firms with a truly international reach. Additional information available at www.allencaron.com and at www.dresnerir.com

Forward Looking Statements

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

Contact Information